|
ATCC
human liver tumor derived cell lines snu387 ![]() Human Liver Tumor Derived Cell Lines Snu387, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human liver tumor derived cell lines snu387/product/ATCC Average 96 stars, based on 1 article reviews
human liver tumor derived cell lines snu387 - by Bioz Stars,
2026-05
96/100 stars
|
Buy from Supplier |
|
Covance
rodent liver tumors ![]() Rodent Liver Tumors, supplied by Covance, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rodent liver tumors/product/Covance Average 86 stars, based on 1 article reviews
rodent liver tumors - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
|
Covance
liver tumor incidence ![]() Liver Tumor Incidence, supplied by Covance, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/liver tumor incidence/product/Covance Average 86 stars, based on 1 article reviews
liver tumor incidence - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
|
Kaggle Inc
liver tumor segmentation challenge dataset ![]() Liver Tumor Segmentation Challenge Dataset, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/liver tumor segmentation challenge dataset/product/Kaggle Inc Average 86 stars, based on 1 article reviews
liver tumor segmentation challenge dataset - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
|
Kaggle Inc
liver tumor segmentation dataset ![]() Liver Tumor Segmentation Dataset, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/liver tumor segmentation dataset/product/Kaggle Inc Average 86 stars, based on 1 article reviews
liver tumor segmentation dataset - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
|
Charles River Laboratories
liver tumors ![]() Liver Tumors, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/liver tumors/product/Charles River Laboratories Average 86 stars, based on 1 article reviews
liver tumors - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
|
ATCC
liver hepg2 cancer cell lines ![]() Liver Hepg2 Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/liver hepg2 cancer cell lines/product/ATCC Average 99 stars, based on 1 article reviews
liver hepg2 cancer cell lines - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
Journal: Journal of Cancer
Article Title: FAM188B promotes progression of hepatocellular carcinoma by regulating YAP/TAZ via interaction with USP10
doi: 10.7150/jca.125659
Figure Lengend Snippet: FAM188B expression is upregulated and associated with poor prognosis in hepatocellular carcinoma (HCC). (A) Expression of FAM188B mRNA in tumor and non-tumor tissues and its association with cancer stage and tumor grade in UALCAN database. (B) The expression of FAM188B protein was evaluated in normal hepatocytes (LX-2) and in hepatocellular carcinoma (HCC) cells (MHCC97H, Huh7, Hep3B and SNU387) by western blot. (C) Validation of FAM188B expression after overexpression in the indicated cell lines using western blotting (n = 3). (D) Proliferation of MHCC97H and Huh7 cells, as detected by performing CCK-8 assays (n = 10). (E) Migratory and invasive capacities of MHCC97H and Huh7 cells within 24 hours, as evaluated using Transwell assays (scale bar, 50 μm) (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant. The data are expressed as the mean ± SD of three independent experiments.
Article Snippet:
Techniques: Expressing, Western Blot, Biomarker Discovery, Over Expression, CCK-8 Assay
Journal: Journal of Cancer
Article Title: FAM188B promotes progression of hepatocellular carcinoma by regulating YAP/TAZ via interaction with USP10
doi: 10.7150/jca.125659
Figure Lengend Snippet: FAM188B interacts with USP10. (A) Schematic illustration of IP and GO enrichment of identified proteins (using all proteins in the species database as the background). Fisher's exact test was used to analyze the significance and P value < 0.05 were considered significant. (B) Expression levels of USP10 mRNA in tumor (n = 374) and non-tumor (n = 50) tissues and its relationship with FAM188B, based on a public database. (C) The protein expression level of USP10 was evaluated in normal hepatocytes (LX-2) and hepatocellular carcinoma (HCC) cells (MHCC97H, Huh7, Hep3B and SNU387) by western blot. (D) Localization of USP10 in HCC cells (scale bar, 20 μm). (E) Co-IP assays to confirm the protein-protein interaction between FAM188B and USP10 in vitro . **p < 0.01, ***p < 0.001. The data are expressed as the mean ± SD of three independent experiments. IP, immunoprecipitation. Co-IP, co-immunoprecipitation.
Article Snippet:
Techniques: Expressing, Western Blot, Co-Immunoprecipitation Assay, In Vitro, Immunoprecipitation
Journal: Naunyn-Schmiedeberg's Archives of Pharmacology
Article Title: Morin hydrate alleviated cisplatin-induced testicular toxicity in rats via modulating NLRP3/NF-κB pathway
doi: 10.1007/s00210-025-04867-5
Figure Lengend Snippet: The MTT cell viability assay showing the cytotoxicity of Cis, MH, and their combination in A the human prostate (PC3), B breast (MCF7), and C liver (HepG2) cancer cell lines. In this dose–response curve, the average percentage viability was plotted on the y -axis against the logarithm of the concentration for each treatment on the x -axis, and the IC 50 (the concentration corresponding to the 50% viability) was calculated
Article Snippet: Human prostate (PC3), breast (MCF7), and
Techniques: Viability Assay, Concentration Assay